New Year's Resolution: Give Pets the Gift of Top-Notch Health Care

BURLINGAME, Calif., Jan. 14, 2014 /PRNewswire/ -- As pet owners drew up their lists of New Year's resolutions for 2014, there's no doubt many of them wrote: "Take better care of my furry companion." Nowadays there are pet salons, dog and cat therapists, and even designer clothes and top-brand carrying cases to take the little canine or feline darlings along wherever mommy or daddy goes. Pet parents might also feel compelled to buy some pricey toys at the pet store. But anyone who has ever lived with a dog or cat knows that most toys can't compete with that chewed-up baseball or shoe left lying around. Instead of spending the big bucks on Prada or Chanel couture for their cockapoo, pet owners should consider saving money for what really matters: the very best health care.

Keeping pets healthy starts with their owners. Feeding one's "baby" the correct food—and not letting it constantly munch on scraps from the dinner table—is step one. Many pet disorders originate from eating incompatible human foods. Step two is monitoring a pet's body and noting any changes. When a pet gets a belly rub, attention should be paid to any lumps, bumps or discolorations. A dog that limps when taken for a walk could be nothing serious—or the first sign of potentially serious medical issues. For human or beast alike, early detection is always a good way to find the ideal treatment.

One company is determined to help pet owners find those ideal treatments: Kindred Biosciences, Inc., a groundbreaking biopharmaceutical company headquartered in San Francisco. Kindred Bio is passionately dedicated to researching and developing the best medications for dogs, cats and horses.

"Our mission is simple," said Richard Chin, M.D., Kindred Bio's Founder and CEO. "We strive to bring the very best science and medicine to our animal companions." The company is currently developing a series of products including CereKin for osteoarthritis pain in dogs and horses; AtoKin for atopic dermatitis in dogs; and SentiKin for post-operative pain in dogs and horses. "We believe our research will relieve suffering and potentially save animals' lives," Chin adds.

For more information, visit www.kindredbio.com, who paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210

SOURCE Kindred Biosciences, Inc.



RELATED LINKS
http://www.kindredbio.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.